Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makito Miyake

Showing results (11-20 of 420) with videos related to

Pageof 42
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 14, 2022
Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaMakito Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Ⅱ. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer]Makito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2025
Editorial Comment From Dr. Miyake to Effects of Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial CarcinomaMakito Miyake
Translational Andrology and Urology|December 4, 2018
Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomyMakito Miyake, Kiyohide Fujimoto
Annals of Translational Medicine|October 3, 2019
Lack of evidence regarding bone metastases of genitourinary cancers: interventions by surgery, radiotherapy, and bone-targeted systemic therapyMakito Miyake, Takuya Owari, Kiyohide Fujimoto
Investigative and Clinical Urology|June 22, 2016
Active surveillance for nonmuscle invasive bladder cancerMakito Miyake, Kiyohide Fujimoto, Yoshihiko Hirao
Annals of Translational Medicine|April 30, 2019
Potential biological and clinical benefit of prostate-directed interventions in patients with metastatic prostate cancerMakito Miyake, Takuya Owari, Nobumich Tanaka, et al.
Translational Andrology and Urology|August 9, 2019
Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancerMakito Miyake, Takuya Owari, Shunta Hori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2023
Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated diseaseMakito Miyake, Nobutaka Nishimura, Tomomi Fujii, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 13, 2006
[Paravesical suture abscess diagnosed 4 years after transvaginal uterectomy]Makito Miyake, Kenji Takashima, Tadashi Hiramatsu, et al.
Pageof 42

Showing results (11-20 of 420) with videos related to

Sort By:
Pageof 42
International Journal of Urology : Official Journal of the Japanese Urological Association|January 14, 2022
Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinomaMakito Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Ⅱ. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer]Makito Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2025
Editorial Comment From Dr. Miyake to Effects of Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial CarcinomaMakito Miyake
Translational Andrology and Urology|December 4, 2018
Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomyMakito Miyake, Kiyohide Fujimoto
Annals of Translational Medicine|October 3, 2019
Lack of evidence regarding bone metastases of genitourinary cancers: interventions by surgery, radiotherapy, and bone-targeted systemic therapyMakito Miyake, Takuya Owari, Kiyohide Fujimoto
Investigative and Clinical Urology|June 22, 2016
Active surveillance for nonmuscle invasive bladder cancerMakito Miyake, Kiyohide Fujimoto, Yoshihiko Hirao
Annals of Translational Medicine|April 30, 2019
Potential biological and clinical benefit of prostate-directed interventions in patients with metastatic prostate cancerMakito Miyake, Takuya Owari, Nobumich Tanaka, et al.
Translational Andrology and Urology|August 9, 2019
Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancerMakito Miyake, Takuya Owari, Shunta Hori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2023
Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated diseaseMakito Miyake, Nobutaka Nishimura, Tomomi Fujii, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 13, 2006
[Paravesical suture abscess diagnosed 4 years after transvaginal uterectomy]Makito Miyake, Kenji Takashima, Tadashi Hiramatsu, et al.
Pageof 42